Why Macy’s Shares Are Trading Higher Today
Macy’s Inc (NYSE: M) reported a fourth-quarter FY22 sales decline of 4.6% year-on-year to $8.26 billion, beating the consensus of $8.25…
Tecnoglass FY23 Revenue Outlook $790M – $830M Vs. $795.13M Estimate
Full Year 2023 Outlook
Santiago Giraldo, Chief Financial Officer of Tecnoglass, stated, "Based on our current invoicing schedule and strong demand for our architectural glass products, we are pleased to
Everspin Technologies Sees Q1 EPS $0.05 Vs $0.04 Est.; Q1 Revenue $14.1M-$14.4M Vs $14.5M Est.
Business Outlook
For the first quarter 2023, Everspin is confident in its future opportunities and ability to navigate macroeconomic challenges. Everspin expects total revenue in a range of $14.1
Repay Holdings Sees FY23 Revenue $272M-$288M Vs $301.09M Est.
2023 Outlook
"In 2023, we will continue to invest in growth opportunities across our Consumer and Business Payments segments," said Tim Murphy, CFO of REPAY. "We aim to achieve double digit organic
Ginkgo Bioworks Sees FY23 Revenue $275M Vs $381.51M Est
Full Year 2023 Guidance
Ginkgo expects to add 100 new Cell Programs to the Foundry platform in 2023
Ginkgo expects Total revenue of at least $275 million in 2023
Ginkgo expects Foundry revenue of
Zuora Sees Q1 EPS $0.00-$0.01 Vs $0.00 Est.; Q1 Revenue $101M-$103M Vs $102.75M Est.; FY24 EPS $0.07-$0.11 Vs $0.08 Est.; FY24 Revenue $428M-$440M Vs $432.01M Est.
Financial Outlook:
As of March 1, 2023, we are providing guidance for the first quarter and full fiscal year 2024 based on current market conditions and expectations. We emphasize that
Jazz Pharmaceuticals Sees FY23 EPS $16.90-$17.85 Vs $18 Est.; FY23 Revenue $3.675B-$3.875B Vs $3.76B Est.
2023 Financial Guidance
Jazz Pharmaceuticals' full year 2023 financial guidance is as follows:
(In
Box Sees Q1 EPS $0.26-$0.27 Vs $0.3 Est.; Q1 Revenue $248M-$250M Vs $260.24M Est.; Sees FY23 EPS $1.42-$1.48 Vs $1.47 Est.; FY23 Revenue $$1.05B-$1.06B Vs $1.1B Est.
Outlook
The following guidance includes the impact of any expected foreign exchange headwinds, assuming present foreign currency exchange rates.
Q1 FY24 Guidance
Revenue is expected to be in the
Why Invitae Corporation Shares Are Falling Today
Invitae Corporation (NYSE: NVTA) shares are trading lower this Wednesday after the company reported fourth-quarter financial results and provided guidance for full-year 2023. The company also announced that it has signed exchange and financing agreements with a fund managed by Deerfield Management C
Why Payoneer Global Stock Is Trading Higher Today
Payoneer Global (NASDAQ: PAYO) shares are trading higher after the company reported better-than-expected fourth-quarter EPS and issued full-year 2023 guidance above estimates.